Pharmacy alerts

  • National Patient Safety Alert for Steriflex® No. 109 (1L) and No. 171 (2L): potassium chloride 0.15%, sodium chloride 0.45%, glucose 2.5% bags

    National Patient Safety Alert: The DHSC has published a National Patient Safety Alert regarding supply issues affecting products in the Steriflex® range.

  • Improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines and z-drugs

    Drug safety update: The MHRA has published a drug safety update following a review of the warnings accompanying gabapentin, pregabalin, benzodiazepines, and z-drugs.

  • Nestlé recalls SMA Infant Formula and Follow-On Formula

    Food Standards Agency alert: The Food Standards Agency has published an alert for SMA Infant Formula and Follow-On Formula.

  • Rybelsus (semaglutide tablets): transition to new formulation and risk of medication error

    Drug Safety Update: The MHRA has published a Drug Safety Update for Rybelsus (semaglutide) tablets.

  • Activase Pharmaceuticals Limited, Prednisolone 5mg soluble tablets recall

    Class 3 medicines recall: The MHRA has published a Class 3 medicines recall for prednisolone 5mg soluble tablets.

  • The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 approved

    The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 was approved by Parliament and the Privy Council on the 11th December.